Skip to main content
Clinical Trials/CTRI/2023/11/059565
CTRI/2023/11/059565Not yet recruitingPhase 2

A clinical study to evaluate the effect of Bharangyadi Kwatha & Kaliphala Churna in the management of Shwasa Roga w.s.r. to Chronic Obstructive Pulmonary Disease(COPD)

Dr Anjana Mishra1 site in 1 country30 target enrollmentStarted: November 20, 2023Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
A clinical study to evaluate the effect of Bharangyadi Kwatha & Kaliphala churna in the management of Shwasa Roga w.s.r. to Chronic obstructive Pulmonary Disease (COPD)

Study Overview

Brief Summary

I wish to publish my research work after completion of my trial. A total no of 30 patients will be selected from OPD and IPD of Kayachikitsa Department in Rajiv Gandhi Govt Post Graduate Ayurvedic College and hospital Paprola Distt Kangra, H.P. Two groups of 15 patients each will be managed with bharangyadi kwatha and kaliphala churna respectively in the management of Shwasa roga w. s. r. To Chronic obstructive Pulmonary Disease.

Study Design

Study Type
Interventional
Allocation
Other
Masking
Open Label

Eligibility Criteria

Ages
40.00 Year(s) to 80.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients having Prolonged expiration with pursed lip breathing, barrel shaped chest, central or peripheral cyanosis, diminished expansion of chest,use of accessory muscles.

Exclusion Criteria

  • Patients presenting with complications like advanced type 2 respiratory failure, lung collapse and pneumothorax Patients showing more than 12% increment in FEV1/FVC ratio after bronchodilation with 2 puffs of salbutamol 100mcg/puff.

Outcomes

Primary Outcomes

A clinical study to evaluate the effect of Bharangyadi Kwatha & Kaliphala churna in the management of Shwasa Roga w.s.r. to Chronic obstructive Pulmonary Disease (COPD)

Time Frame: 30 days

To compare the effect of Bharangyadi Kwatha and Kaliphala Churna with Doxophylline in the management of Shwasa Roga w.s.r.to Chronic Obstructive Pulmonary Disease (COPD)

Time Frame: 30 days

Secondary Outcomes

  • To assess the clinical safety of Bharangyadi Kwatha & Kaliphala Churna in the management of Shwasa Roga w.s.r to Chronic Obstructive pulmonary Disease (COPD)(30 days)

Investigators

Sponsor
Dr Anjana Mishra
Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials